Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

288 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.
Roth MD, Gitlitz BJ, Kiertscher SM, Park AN, Mendenhall M, Moldawer N, Figlin RA. Roth MD, et al. Among authors: figlin ra. Cancer Res. 2000 Apr 1;60(7):1934-41. Cancer Res. 2000. PMID: 10766183 Clinical Trial.
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.
Figlin RA, Belldegrun A, Moldawer N, Zeffren J, deKernion J. Figlin RA, et al. J Clin Oncol. 1992 Mar;10(3):414-21. doi: 10.1200/JCO.1992.10.3.414. J Clin Oncol. 1992. PMID: 1482425 Clinical Trial.
Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
Hofmann B, Bass H, Nishanian P, Faisal M, Figlin RA, Sarna GP, Fahey JL. Hofmann B, et al. Among authors: figlin ra. Clin Exp Immunol. 1992 Jun;88(3):548-54. doi: 10.1111/j.1365-2249.1992.tb06485.x. Clin Exp Immunol. 1992. PMID: 1606739 Free PMC article.
Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment.
Ross HJ, Moy LA, Kaplan R, Figlin RA. Ross HJ, et al. Among authors: figlin ra. Cancer. 1991 Jul 15;68(2):441-3. doi: 10.1002/1097-0142(19910715)68:2<441::aid-cncr2820680239>;2-4. Cancer. 1991. PMID: 1712666
The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.
Figlin RA, Abi-Aad AS, Belldegrun A, deKernion JB. Figlin RA, et al. Semin Oncol. 1991 Oct;18(5 Suppl 7):102-7. Semin Oncol. 1991. PMID: 1719641 Review.
Thyroid function abnormalities associated with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferon-alpha.
Jacobs EL, Clare-Salzler MJ, Chopra IJ, Figlin RA. Jacobs EL, et al. Among authors: figlin ra. J Immunother (1991). 1991 Dec;10(6):448-55. doi: 10.1097/00002371-199112000-00009. J Immunother (1991). 1991. PMID: 1768679
Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection.
Abi-Aad AS, Figlin RA, Belldegrun A, deKernion JB. Abi-Aad AS, et al. Among authors: figlin ra. J Immunother (1991). 1991 Aug;10(4):292-5. J Immunother (1991). 1991. PMID: 1931865
Atypical contrast reactions associated with systemic interleukin-2 therapy.
Fishman JE, Aberle DR, Moldawer NP, Belldegrun A, Figlin RA. Fishman JE, et al. Among authors: figlin ra. AJR Am J Roentgenol. 1991 Apr;156(4):833-4. doi: 10.2214/ajr.156.4.2003450. AJR Am J Roentgenol. 1991. PMID: 2003450 No abstract available.
A pilot study of intralymphatic interleukin-2. II. Clinical and biological effects.
Sarna G, Collins J, Figlin R, Robertson P, Altrock B, Abels R. Sarna G, et al. J Biol Response Mod. 1990 Feb;9(1):81-6. J Biol Response Mod. 1990. PMID: 2319262
Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?
Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J. Ganz PA, et al. Among authors: figlin ra. Cancer. 1989 Apr 1;63(7):1271-8. doi: 10.1002/1097-0142(19890401)63:7<1271::aid-cncr2820630707>;2-6. Cancer. 1989. PMID: 2465815 Clinical Trial.
288 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page